AbstractCOVID 19 has spread uniformly across the planet without distinction of hemispheres, borders, or climates. However, underdeveloped countries lack sufficient means to effectively detect and cope with the pandemic. The catastrophic economic situation forces indefinite quarantines to avoid health collapse. The scarcity of massive detection tests has led health personnel, the general population and their rulers to ignorance of the true epidemiological magnitude of SARS-CoV-2. Method: A computerized bibliographic search was performed using the Google search engine of original and review articles indexed by Scopus and WOS, in the PubMed / Medline and Cochrane databases to identify all relevant manuscripts and preprints, notices from professional societies and comments from Experts published from the start of the current epidemic related to mild COVID 19 symptoms. Tools, massive methods for detecting the disease and their low availability in underdeveloped countries were analyzed. Inexpensive and easily accessible methods for testing for the disease were discussed. Result: According to the indexed publications on the incidence of hypoxemia as a symptom and parameter of the evolution of the disease, oxygen saturation of less than 93% was determined as the limit to consider the patient suspected of COVID 19. In addition, it was determined after the analysis of published studies show an average prevalence of anosmia-hyposmia as a mild symptom in 69% of patients infected with COVID 19. Conclusion: Suspected cases of COVID 19 infection could be detected by the presence of its prevalent signs and symptoms. More studies are needed to standardize and validate the postulated screening tests.
Registro 03/03/20-20/04/20 Hospital Alto Guadalquivir, Andújar, España.
Chung TW, Sridhar S, Zhang AJ. Olfactory Dysfunction in Coronavirus Disease 2019 Patients: Observational Cohort Study and Systematic Review. Open Forum Infect Dis. 2020;7(6).
Coronavirus disease 2019 - World Health Organization.
Zhang JJ, Dong X, Cao YY, Yuan YD, Yang YB, YQ Y. Clinical characteristics of 140 patients infected by SARS-CoV-2 in Wuhan, China. Allergy. 2020;
Wang D, Hu B, Hu C, Zhu F, Liu X, J Z. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;
Paraskevis D, Kostaki EG, Magiorkinis G, Panayiotakopoulos G, Sourvinos G, Tsiodras S. Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event. Infect Genet Evol. 2020;79(104212).
Chen L, Liu W, Zhang Q, Xu K, Ye G, Wu W. RNA based mNGS approach identifies a novel human coronavirus from two individual pneumonia cases in 2019 Wuhan outbreak. Emerg Microb Infect. 2020;9:313–319.
Fan W, Su Z, Bin Y, Yan-Mei C, Wen W, Zhi-Gang S, et al. Holmes Edward C., Zhang Yong-Zhen. A new coronavirus associated with human respiratory disease in China. Nature. 2020;579(7798):265–9.
Zhu N, Zhang D, Wang W. China Novel Coronavirus Investigating and Research Team. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382(8).
Huang C, Wang Y, Li X. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497–506.
Chan JF, Yuan S, Kok KH. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to- person transmission: a study of a family cluster. Lancet. 2020;395:514–23.
Pons S, Fodil S, Azoulay E, Zafrani L. The vascular endothelium: the cornerstone of organ dysfunction in severe SARS-CoV-2 infection. Crit Care. 2020;24(1).
Carsana L, Sonzogni A, Nasr A. Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive study. The Lancet Infectious Diseases. I(ttps://doi.org/10.1016/S1473-3099(20)30434-5).
Mucha SR, Dugar S, McCrae K, Joseph DE, Bartholomew J, Sacha G, et al. Coagulopathy in COVID-19. Cleveland Clinic Journal of Medicine Jun. 2020;
Lippi G, Favaloro EJ. D-dimer is Associated with Severity of Coronavirus Disease 2019: A Pooled Analysis. Thromb Haemost. 2020 Apr 3;
Siddiqi HK, Mehra MR. COVID-19 illness in native and immunosuppressed states: A clinical-therapeutic staging proposal. J Heart Lung Transplant. 2020;39(5):405–407.
Zhai P, Ding Y, Wu X, Long J, Zhong Y, Li Y. Epidemiología, diagnóstico y tratamiento de COVID-19. Int J Antimicrob Agents. 2020;55(5):105955.
Boukhris M, Hillani A, Moroni F. Cardiovascular Implications of the COVID-19 Pandemic: A Global Perspective. Can J Cardiol. 2020;36(7):1068–1080.
Udugama B, Kadhiresan P, Kozlowski HN. Diagnosing COVID-19: The Disease and Tools for Detection. ACS Nano. 2020;14(4):3822–3835.
D.P O, E.J T. Prevalence of Asymptomatic SARS-CoV-2 Infection. A Narrative Review Annals of internal medicine [Internet]. 2020 Jun 3; Available from: https://doi.org/10.7326/M20-3012
Tobin MJ, Laghi F, Jubran A. Why COVID-19 Silent Hypoxemia Is Baffling to Physicians. Am J Respir Crit Care Med. 2020;202(3):356–360.
Yan CH, Faraji F, Prajapati DP, Boone CE, DeConde AS. Association of chemosensory dysfunction and Covid-19 in patients presenting with influenza-like symptoms. International forum of allergy & rhinology. 2020 n/a(n/a;
Duca A, Piva S, Focà E, Latronico N, Rizzi M. Calculated Decisions: Brescia-COVID Respiratory Severity Scale (BCRSS)/Algorithm. Emerg Med Pract. 2020;22(5 Suppl).
Dhont S, Derom E, Van Braeckel E. The pathophysiology of ‘happy’ hypoxemia in COVID-19. Respir Res. 2020;21:198.
Machhi J, Herskovitz J, Senan AM. The Natural History, Pathobiology, and Clinical Manifestations of SARS-CoV-2 Infections. J Neuroimmune Pharmacol [Internet]. 2020; Available from: https://doi.org/10.1007/s11481-020-09944-5
American Academy of Otolaryngology Head and Neck Surgery. Coronavirus Disease 2019: Resources [Internet]. 2020. Available from: https://wwwentnetorg/content/coronavirus-disease-2019-resources.
Kaye R, Chang CWD, Kazahaya K, Brereton J. Denneny JC 3rd. COVID-19 Anosmia Reporting Tool: Initial Findings. Otolaryngol Head Neck Surg. 2020;163(1):132–134.
Brodwin E. Doctors warn an inability to smell could be a symptom of COVID-19—but caution the evidence is preliminary [Internet]. 2020. Available from: https://www.statnews.com/2020/03/23/coronavirus-sense-of-smellanosmia/
Sedaghat AR, Gengler I, Speth MM. Olfactory Dysfunction: A Highly Prevalent Symptom of COVID-19 With Public Health Significance. Otolaryngol Head Neck Surg. Vol. 163. 2020. 12–15 p.
Gilani S, Roditi R, Naraghi M. COVID-19 and anosmia in Tehran, Iran. Med Hypotheses. 2020;141(109757).
Spinato G, Fabbris C, Polesel J. Alterations in Smell or Taste in Mildly Symptomatic Outpatients With SARS-CoV-2 Infection [published online ahead of print, 2020 Apr 22. JAMA. 2020;323(20):2089–2090.
L VG, PW H, T C, W F, C H, V H, et al. Personal protection and delivery of rhinologic and endoscopic skull base procedures during the COVID-19 outbreak. Rhinology. 2020 Jun 1;58(3):289–294.
Yan CH, Faraji F. DeConde AS Reply to: Self-reported olfactory loss in COVID-19: is it really a favorable prognostic factor? Int Forum Allergy Rhinol. 2020 Jul;10(7):927–928.
Vaira LA, Salzano G, Petrocelli M, Deiana G, Salzano FA, De Riu G. Validation of a self-administered olfactory and gustatory test for the remotely evaluation of COVID-19 patients in home quarantine. Head Neck. 2020 Jul;42(7):1570–1576.
Ortiz-Prado E, Simbaña-Rivera K, Gómez-Barreno L. Clinical, molecular, and epidemiological characterization of the SARS-CoV-2 virus and the Coronavirus Disease 2019 (COVID-19), a comprehensive literature review. Diagn Microbiol Infect Dis. 2020;98 1 115094.
Stawicki SP, Jeanmonod R, Miller AC. The 2019-2020 Novel Coronavirus (Severe Acute Respiratory Syndrome Coronavirus 2) Pandemic: A Joint American College of Academic International Medicine-World Academic Council of Emergency Medicine Multidisciplinary COVID-19 Working Group Consensus Paper. J Glob Infect Dis. 2020;12(2):47–93.
Xie J, Covassin N, Fan Z. Association Between Hypoxemia and Mortality in Patients With COVID-19. Mayo Clin Proc. 2020;95(6):1138–1147.
Coincidence of COVID-19 epidemic and olfactory dysfunction outbreak | medRxiv [Internet]. [cited 2020 Aug 26]. Available from: https://www.medrxiv.org/content/10.1101/2020.03.23.20041889v1
Haehner A, Draf J, Draeger S, With K, Hummel T. Predictive value of sudden olfactory loss in the diagnosis of COVID-19. 2020.
Byambasuren O, Cardona M, Bell K, Clark J, McLaws M-L, Glasziou P. Estimating the extent of asymptomatic COVID-19 and its potential for community transmission: systematic review and meta-analysis [Internet]. Available from: https://doi.org/10.1101/2020.05.10.20097543
Lechien JR, Chiesa-Estomba CM, Siati DRD, Horoi M, Bon SDL, Rodriguez A, et al. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur Arch Otorhinolaryngol. 2020;Apr 6:1–11.
Luks AM, Swenson ER. Pulse Oximetry for Monitoring Patients with COVID-19 at Home: Potential Pitfalls and Practical Guidance. AnnalsATS [Internet]. Available from: https://doi.org/10.1513/AnnalsATS.202005-418FR
Hannum ME, Ramirez VA, Lipson SJ. Objective sensory testing methods reveal a higher prevalence of olfactory loss in COVID-19 positive patients compared to subjective methods: A systematic review and meta-analysis. Preprint.
L H. Test para evaluación de alteraciones olfatorias: Parte I Poster. In: Encuentro Primavera 2011 Instituto Nacional de Tecnología Industrial. Argentina;
Geng YJ, Wei ZY, Qian HY, Huang J, Lodato R, Castriotta RJ. Pathophysiological characteristics and therapeutic approaches for pulmonary injury and cardiovascular complications of coronavirus disease 2019. Cardiovasc Pathol. 2020;47(107228).
Kissler SM, Tedijanto C, Goldstein E, Grad YH, Lipsitch M. Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period. Science. 2020;368(6493):860–868.
J.J VR. La efectividad de la detección precoz de enfermedades An Sist Sanit Navar. Vol. 30. 2007. 11–27 p.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.